FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 301 through 309 of 309

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
WHWK Nasdaq Whitehawk Therapeutics, Inc. 2836
WINT Nasdaq Windtree Therapeutics, Inc. 2836
WVE Nasdaq Wave Life Sciences Ltd. 2836
XENE Nasdaq Xenon Pharmaceuticals Inc. 2836
XLO Nasdaq Xilio Therapeutics, Inc. 2836
XNCR Nasdaq Xencor, Inc. 2836
YMAB Nasdaq Y-mAbs Therapeutics, Inc. 2836
ZBIO Nasdaq Zenas BioPharma, Inc. 2836
ZNTL Nasdaq Zentalis Pharmaceuticals, Inc. 2836
Results 300 through 309 of 309